ArticleCancer immunology, immunotherapy : CII2015

Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).

Mario E Lacouture et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.